Graves, D. E.; and Velea, L. M. Intercalating binding of small molecules to nucleic acids. Curr. Org. Chem.2000; 4: 915-929.
Berman; H. M., and Young, P. R. the interaction of intercalating drugs with nucleic acids. Annu. Rev. Biophys. Bioeng.1981; 10: 87-114.
Gago, F. stacking interactions and intercalative DNA binding. Methods.1998; 14: 277-292.
Kapur, A.; Beck, J. L.; and Sheil, M. M. Rapid Commun. Observation of daunomycin and nagolamycin complexes with duplex DNA using electrospray mass spectroscopy. Mass Spectrom.1999; 13: 2489-2497.
Brana, M. F.; Cacho, M.; Gradillas, A.; de Pascual-Teresa, B. and Ramos, A. Intercalators and anticancer drugs. Curr. Pharm. Des.2001; 7: 1745-1780.
Garbett, N. C.; and Graves, D. E. Entending nature’s leads: the anticancer agent ellipticine. Curr. Med. Chem. Anticancer Agents.2004; 4: 149-172.
Gallego, J.; Ortiz, A. R.; de Pascual-Teresa, B.; and Gago, F. J. computational methods on intercalators phenomena. Comput. Aided Mol. Des. 1997; 11: 114-122.
Ewesuedo, R. B.; Iyer, L.; Das, S.; Koenig, A.; Mani, S.; Vogelzang, N. J.; Schilsky, R. L.; Brenckman, W.; and Ratain, M. J. J. anticancer drugs. Clin. Oncol. 2001; 19: 2084-2098.
Ishida, K.; and Asao, T. Observation of daunomycin and nagolamycin complexes with duplex DNA. Nucl. Acids Symp. Ser. 1999; 42: 129-143.
Brana, M. F.; and Ramos, A. naphtalimides as anticancer agents: synthesis and biological activity. Curr. Med. Chem. Anticancer Agents.2001; 1: 237-255.
De Isabella, P.; Zunino, F. and Capranico, G. sequence selectivity of topoisomerase DNA cleavage. Nucleic Acids Res. 1995; 23: 223-254.
Rosell, R.; Carles, J.; Abad, A.; Ribelles, N.; Barnadas, A.; Benavides, A.; and Martin M. Phase study of mitonafide in 120 hour continuous. Invest. New Drugs. 1992; 10: 171-175.
Allen, S. L.; Budman, D. R.; Fusco, D.; Kolitz, J.; Kreis, W.; Schulman, P.; Schuster, M.; DeMarco, L.; Marsh, J.; Haptas, K. and Fischkoff, S. Proc. Am. Assoc. Cancer Res. 1994; 35: 325-331.
Asai, G.; Yamamoto, N.; Toi, M.; Shin, E.; Nishiyama, K.; Sekine, T.; Nomura, Y.; Takashima, S.; Kimura, M., and Tominaga, T. Cancer Chemother. Pharmacol. 2002; 49: 468-478.
Portugal, J. Curr. Med. Chem. Elsamicine A and related anti-cancer antibiotics. Anticancer Agents. 2003; 3: 411-420.
Lambert, B.; Rocques, B. P.; and Le Pecq, J.B. DNA intercalation. Nucleic Acids Res. 1988; 16: 1063-1070.
Gao, Q.; Williams, L. D.; Egli, M.; Rabinovich, D.; Le Chen, S.; Qugley, G.; and Rich, A. DNA induced DNA repair X-ray structure of a DNA-ditercalinium complex. Proc. Natl. Acad. Sci. USA. 1991; 88: 2422-2431.
Brana, M. F.; Castellano, J. M.; Moran, M.; Perez de Vega, M. J.; Romerdahl, C. R.; Qian, X.-D.; Bousquet, P.; Emling, F.; Schlick, E.; and Keilhauer, G. bis naphtalimides: a new class of antitumor agents. Anticancer Drug Des. 1993; 8: 257-268.
Villalona-Calero, M. A.; Eder, J. P.; Toppmeyer, D. L.; Allen, L. F.; Fram, R.; Velagapudi, R.; Myers, M.; Amato, A.; Kagen-Hallet, K.; Razvillas, B., Kufe, D. W., Von Hoff, D. D. DNA-ditercalinium complex. J. Clin. Oncol. 2001; 19: 857-864.
Bailly, C.; Carrasco, C.; Joubert, A.; Bal, C.; Wattez, N.; Hildebrand, M. P.; Lansiaux, A.; Colson, P.; Houssier, C., Cacho, M., Ramos, A., and Brana, M. F. topoisomerase DNA cleavage. Biochemistry. 2003; 42: 4136-4141.
Wadler, S.; Tenteromano, L.; Cazenave, L.; Sparano, J. A.; Greenwald, E. S.; Rozenblit, A.; Kaleya, R., and Wiernik, P. H. naphtalimides as anticancer. Cancer Chemother. Pharmacol. 1994; 34: 266-272.